Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

China Merchants Securities

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 40
Average round size
info
The average size of a deal this fund participated in
$60M
Portfolio companies 36
Rounds per year 1.21
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.07
Exits 17
Key employees 10

Areas of investment

  • Manufacturing
  • Biotechnology
  • Medical
  • Hardware
  • Health Care
Summary

China Merchants Securities appeared to be the Corporate Investor, which was created in 1991. The company was established in Asia in China. The leading representative office of defined Corporate Investor is situated in the Shenzhen.

We also calculated 10 valuable employees in our database.

The fund has no specific favorite in a number of founders of portfolio startups. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Health Care, E-Commerce. For fund there is a match between the location of its establishment and the land of its numerous investments - China. Among the most popular portfolio startups of the fund, we may highlight SenseTime, GRAIL, Kingsoft Cloud.

The typical case for the fund is to invest in rounds with 7 participants. Despite the China Merchants Securities, startups are often financed by IDG Capital, BlueRun Ventures, ARCH Venture Partners. The meaningful sponsors for the fund in investment in the same round are CICC, Zhongping Capital, ZJ Innopark (Zhangjiang Hi-Tech Park). In the next rounds fund is usually obtained by Kingsoft, Tiger Global Management, Temasek Holdings.

The typical startup value when the investment from China Merchants Securities is 500 millions - 1 billion dollars. The usual things for fund are deals in the range of more than 100 millions dollars. The important activity for fund was in 2016. The fund is generally included in less than 2 deals every year. The real fund results show that this Corporate Investor is 20 percentage points more often commits exit comparing to other companies.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of China Merchants Securities:
Typical Co-investors
China Merchants Securities is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after China Merchants Securities:
There are no funds here. If we find new data, we will add it here.

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Aixin Semiconductor Technology

Manufacturing
Semiconductor
Test and Measurement
25 Jan 2024 Guangdong, Tianjin, China

Wei Gao Jie Kang Biological Material

Biotechnology
Manufacturing
Medical
24 Aug 2023 China, China

Porton Advanced Solutions

Biotechnology
Genetics
Manufacturing
Pharmaceutical
Therapeutics
$80M21 Aug 2022 Suzhou, Jiangsu, China

Proton Bio

Biopharma
Biotechnology
Medical
$80M19 Aug 2022 Suzhou, Jiangsu, China

Aoquan

$15M05 Aug 2022 Shanghai, Shanghai, China

Data Grand

$89M09 Mar 2022 Shanghai, China

Regend Therapeutics

Biotechnology
Health Care
Therapeutics
$15M03 Mar 2022 Suzhou, Jiangsu, China

Sheng Microelectronics

Manufacturing
$15M18 Feb 2022 Suzhou, Jiangsu, China

Jifan Biotechnology

Biopharma
Biotechnology
Life Science
Medical Device
$15M13 Dec 2021 Changping, Beijing, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent China Merchants Securities?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 40
Average round size 60M
Rounds per year 1.21
Peak activity year 2016
Lead investments 1
Follow on index 0.07
Exits 17
Group Appearance index 0.93

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Aixin Semiconductor Technology

Manufacturing
Semiconductor
Test and Measurement
25 Jan 2024 Guangdong, Tianjin, China

Wei Gao Jie Kang Biological Material

Biotechnology
Manufacturing
Medical
24 Aug 2023 China, China

Porton Advanced Solutions

Biotechnology
Genetics
Manufacturing
Pharmaceutical
Therapeutics
$80M21 Aug 2022 Suzhou, Jiangsu, China

Proton Bio

Biopharma
Biotechnology
Medical
$80M19 Aug 2022 Suzhou, Jiangsu, China

Aoquan

$15M05 Aug 2022 Shanghai, Shanghai, China

Data Grand

$89M09 Mar 2022 Shanghai, China

Regend Therapeutics

Biotechnology
Health Care
Therapeutics
$15M03 Mar 2022 Suzhou, Jiangsu, China

Sheng Microelectronics

Manufacturing
$15M18 Feb 2022 Suzhou, Jiangsu, China

Jifan Biotechnology

Biopharma
Biotechnology
Life Science
Medical Device
$15M13 Dec 2021 Changping, Beijing, China
Crunchbase icon

Content report

The following text will be sent to our editors: